Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

BACKGROUND: Mycoplasma pneumoniae (Mpn) is a human pathogen that causes acute and chronic respiratory diseases and has been linked to many extrapulmonary diseases. Due to the lack of cell wall, Mpn is resistant to antibiotics targeting cell wall synthesis such as penicillin. During the last 10 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ren, Wang, Liya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750255/
https://www.ncbi.nlm.nih.gov/pubmed/23919755
http://dx.doi.org/10.1186/1471-2180-13-184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750255/
https://www.ncbi.nlm.nih.gov/pubmed/23919755
http://dx.doi.org/10.1186/1471-2180-13-184

Ejemplares similares